Screening for Fabry Disease in a Pediatric Population at Risk
CompletedNCT02152189
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to assess the frequency of Fabry disease in children with chronic abdominal pain or chronic pain in the extremities
Study details
- Conditions
- Chronic Pain in the Extremities
- Chronic Abdominal Pain
- Fabry Disease
- Interventions
- Other: Screening for Fabry disease
- Sponsor
- University Hospital Heidelberg
- Start date
- 2014-05
- Primary completion
- 2017-05
- Sex
- All
- Age range
- to 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Germany
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age below 18 years * One of the following criteria: * Diagnosis or suspicion of a rheumatological disorder with recurrent complaints for more than 6 months * Chronic, recurrent abdominal pain for more than 6 months * Planned blood sample for routine diagnostics * Written informed consent Exclusion Criteria: \- Patient and/or the patient's parent(s) or legal guardian(s) are unable to understand the nature, scope, and possible consequences of the screening.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02152189